Corporates Zydus receives USFDA approval for Methenamine Hippurate Tablets USP, 1 gram Aman Shukla Mar 12, 2025
Stock Market Zydus Lifesciences shares surge nearly 3% after US FDA issues no observations for… Aman Shukla Feb 17, 2025
Corporates Zydus and Beihai Biotech sign strategic agreement for BEIZRAY product for the US… Aman Shukla Feb 14, 2025
Corporates Zydus’ Topical manufacturing facility clears USFDA inspection with zero… Aman Shukla Feb 14, 2025
Corporates Zydus signs exclusive agreement with Synthon for a novel 505(B)(2) oncology… Aman Shukla Feb 12, 2025
Corporates Zydus gets USFDA approval for Phase II(b) trial of Usnoflast in ALS treatment Aman Shukla Jan 18, 2025
Corporates Zydus signs strategic agreement with CVS Caremark to add Zituvio , Zituvimet and… Aman Shukla Jan 7, 2025
Corporates Zydus Life to divest 6.5% stake in Mylab Discovery Solutions for Rs 106 crore Aditya Bhagchandani Dec 16, 2024
Stock Market Citi maintains its Sell call on Zydus, expressed concerns over Sterling Biotech… Markets Desk Aug 26, 2024
Business Zydus receives final approval from the USFDA for its NDA Zituvimet TM XR extended… Aman Shukla Jul 19, 2024
Pandemic DCGI aprroves use of Zydus’s Virafin in treating moderate COVID-19 infection News Desk Apr 23, 2021
